Overview Fundamentals API Earnings EOD API Sample Code Pricing

Tarsus Pharmaceuticals Inc (TARS NASDAQ) stock market data APIs

$30.6 -0.65(-2.1%) as of September 9, 2024
Price chart is built with Anychart

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Tarsus Pharmaceuticals Inc Financial Data Overview

31.25
30.6
-
32.1
29.92
12.57-42.5
1 189 M
38 042 K
83 374 K
-0.88
1.067
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TARS',
Type: 'Common Stock',
Name: 'Tarsus Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00RB9BNQ7',
ISIN: NULL,
CUSIP: NULL,
CIK: '1819790',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-10-16',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Tarsus Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 83 374 K
  • EBITDA -155 271 008
  • Earnings Per Share -4.46
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Tarsus Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-08-08
  • EPS/Forecast -0.92

Get Tarsus Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com